 |
市场调查报告书
商品编码
1899201
静脉输液帮浦市场规模、份额和成长分析（按产品、疾病、应用和地区划分）－2026-2033年产业预测Intravenous Infusion Pump Market Size, Share, and Growth Analysis, By Product (Volumetric Infusion Pumps, Insulin Infusion Pumps), By Disease Indication (Diabetes, Chemotherapy), By End-use, By Region - Industry Forecast 2026-2033 |
||||||
全球静脉输液帮浦市场规模预计在 2024 年达到 175.4 亿美元，从 2025 年的 189.4 亿美元成长到 2033 年的 350.6 亿美元，在预测期（2026-2033 年）内复合年增长率为 8%。
全球静脉输液帮浦市场正经历强劲成长，主要驱动因素包括慢性病盛行率上升、人口老化以及医疗技术的创新。这些关键的医疗设备能够确保将液体、药物和营养物质精准地输送到患者的血液中。居家医疗服务需求的不断增长以及临床环境中对精准给药的需求，正显着影响着市场。此外，减少用药错误和提高病人安全性的日益重视，也进一步加速了市场扩张。静脉输液帮浦产业的未来取决于开发出使用者友好、互联互通且注重病患安全和治疗效果的设备。持续整合数据驱动技术和以患者为中心的设计，预计将透过满足医疗专业人员和患者不断变化的需求，塑造市场趋势。
全球静脉输液帮浦市场驱动因素
癌症、糖尿病和心血管疾病等慢性病的发病率上升，以及全球人口老化，正显着推动静脉输液帮浦的需求。这些关键设备在为长期照护患者精准输注药物、液体和营养方面发挥着至关重要的作用，有助于更好地管理疾病并改善健康结果。随着越来越多的患者寻求长期护理，对高效静脉输液系统的依赖性也日益增强，凸显了这些设备在现代医疗保健环境中的重要性。
全球静脉输液帮浦市场限制因素
全球静脉输液帮浦市场面临许多挑战，其中最主要的原因是先进型号的高成本。除了初始购置费用外，持续的校准、维护和人员培训等费用也会对医疗预算造成沉重负担。这种经济压力对医疗机构构成重大障碍，尤其是在资源匮乏、资金紧张的地区。这会阻碍这些关键设备的普及，并影响预算紧张地区患者照护品质。因此，必须认真考虑成本问题，才能提高这些重要技术的普及率。
全球静脉输液帮浦市场趋势
全球静脉输液帮浦市场正蓬勃发展，智慧连网输液帮浦凭藉其先进的技术和互联功能，正获得广泛应用。这些创新设备能够辅助剂量计算，与电子健康记录 (EHR) 系统无缝集成，并实现输液参数的即时监测。这项技术革新对于提升病患安全、优化医疗工作流程以及透过远端监测和调整来减少用药错误至关重要。随着数位化医疗解决方案的日益普及，医疗机构正越来越多地采用智慧输液帮浦作为提高给药效率和准确性的重要工具。
目录
介绍
- 调查目标
- 市场定义和范围
调查方法
- 调查过程
- 二手资料和一手资料方法
- 市场规模估算方法
- 市场假设与限制
执行摘要
- 全球市场展望
- 市场主要亮点
- 细分市场概览
市场动态与展望
- 总体经济指标
- 驱动因素和机会
- 限制与挑战
- 供给面趋势
- 需求面趋势
- 波特的分析和影响
关键市场考察
- 关键成功因素
- 市场影响指数
- 关键投资机会
- 市场吸引力指数
- 市场生态系统
- PESTEL 分析
- 监管环境
- 价值链分析
- 专利分析
- 案例研究分析
- 定价分析
全球静脉输液帮浦市场规模（依产品划分）（2019-2032 年）
- 正排量输液泵
- 胰岛素输注泵
- 注射帮浦
- 肠内输液泵
- 病人自控式镇痛帮浦（PCA）
- 家用输液泵
- 其他产品
全球静脉输液帮浦市场依疾病分类（2019-2032 年）
- 糖尿病
- 化疗
- 小儿科/新生儿科
- 血液学
- 其他的
全球静脉输液帮浦市场规模（依技术划分）（2019-2032 年）
- 智慧型输液帮浦
- 传统输液帮浦
全球静脉输液帮浦市场规模（依价格分布）（2019-2032 年）
- 经济实惠的价格分布
- 中价格分布
- 优质的
全球静脉输液帮浦市场规模（按应用领域划分）（2019-2032 年）
- 医院和诊所
- 居家医疗
- 门诊手术中心（ASC）
- 其他的
全球静脉输液帮浦市场规模（2019-2032 年）
- 北美（按产品、疾病、技术、价格分布和应用划分）
- 美国
- 加拿大
- 欧洲（按产品、疾病、技术、价格分布和应用划分）
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲地区
- 亚太地区（依产品、疾病、技术、价格分布和应用划分）
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
- 拉丁美洲（按产品、疾病、技术、价格分布和应用划分）
- 巴西
- 墨西哥
- 其他拉丁美洲地区
- 中东和非洲（按产品、疾病、技术、价格分布和应用划分）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区
竞争对手仪錶板
- 前五大公司对比
- 主要企业的市场定位（2025 年）
- 主要市场参与者所采取的策略
- 近期市场趋势
- 公司市占率分析（2025 年）
主要企业简介
- Becton, Dickinson and Company（BD）
- The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
- Baxter International Inc.
- B. Braun SE
- ICU Medical, Inc.
- Fresenius Kabi
- Terumo Corporation
- Vygon SA
- Medtronic plc
- Mindray
- Nipro Corporation
- Trivitron Healthcare
- Moog, Inc.
- Iradimed
- Arcomed AG
- Micrel Medical Devices
- Woo Young Medical
- InfuSystem Holdings, Inc.
- JMS Co., Ltd.
- Eitan Medical
- Plenum Tech Pvt. Ltd.
结论与建议
Global Intravenous Infusion Pump Market size was valued at USD 17.54 Billion in 2024 and is poised to grow from USD 18.94 Billion in 2025 to USD 35.06 Billion by 2033, growing at a CAGR of 8% during the forecast period (2026-2033).
The global intravenous (IV) infusion pump market is witnessing robust growth, primarily driven by the rising incidence of chronic diseases, an expanding elderly population, and innovations in medical technology. These essential devices ensure precise delivery of fluids, medications, and nutrients into patients' bloodstreams. Increasing demand for home healthcare services and the necessity for accurate drug administration in clinical environments are significant market influencers. Additionally, the emphasis on minimizing medication errors and enhancing patient safety further accelerates market expansion. The future of the IV infusion pump sector hinges on the development of user-friendly, connected devices that focus on patient safety and treatment effectiveness. The ongoing integration of data-driven technologies and patient-centric designs is anticipated to shape market trends, meeting the evolving requirements of healthcare professionals and patients alike.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Infusion Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Intravenous Infusion Pump Market Segments Analysis
Global Intravenous Infusion Pump Market is segmented by Product, Disease Indication, Technology, Price Range, End Use and region. Based on Product, the market is segmented into Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Patient-controlled Analgesia Pumps (PCA), Ambulatory Infusion Pumps and Other Products. Based on Disease Indication, the market is segmented into Diabetes, Chemotherapy, Pediatrics/Neonatology, Hematology and Others. Based on Technology, the market is segmented into Smart Infusion Pumps and Traditional Infusion Pumps. Based on Price Range, the market is segmented into Economical, Mid-Range and Premium. Based on End Use, the market is segmented into Hospitals & Clinics, Home Care, Ambulatory Surgical Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Intravenous Infusion Pump Market
The rising incidence of chronic illnesses like cancer, diabetes, and cardiovascular conditions, along with a worldwide aging demographic, is significantly boosting the demand for intravenous (IV) infusion pumps. These critical devices play a vital role in the precise delivery of medications, fluids, and nutrients to patients undergoing extended treatments, thus enhancing disease management and fostering improved health outcomes. As more individuals seek long-term care solutions, the reliance on effective IV infusion systems continues to grow, highlighting the essential nature of these tools in modern healthcare settings.
Restraints in the Global Intravenous Infusion Pump Market
The global market for intravenous infusion pumps faces significant challenges due to the high costs associated with advanced models. Both the initial purchase price and the ongoing expenses related to calibration, maintenance, and staff training can exert considerable pressure on healthcare budgets. This financial burden poses a significant obstacle for healthcare facilities, particularly in areas with limited resources or constrained financial capabilities. As a result, the adoption of these essential devices may be hindered, impacting the overall quality of patient care in regions struggling with budgetary constraints. A careful consideration of costs will be necessary to enhance accessibility to these critical technologies.
Market Trends of the Global Intravenous Infusion Pump Market
The Global Intravenous Infusion Pump market is experiencing a robust trend towards the adoption of smart and connected infusion pumps, which harness advanced technology and connectivity features. These innovative devices facilitate dose calculation, integrate seamlessly with electronic health records (EHR) systems, and enable real-time monitoring of infusion parameters. This technological evolution is pivotal in enhancing patient safety, optimizing healthcare workflow, and allowing for remote monitoring and adjustments, thereby minimizing medication errors. As digital healthcare solutions increasingly gain traction, healthcare providers are adopting smart infusion pumps as essential tools for improving the efficiency and accuracy of medication administration processes.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impact Factor
- Top Investment Pockets
- Market Attractiveness Index
- Market Ecosystem
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
- Patent Analysis
- Case Study Analysis
- Pricing Analysis
Global Intravenous Infusion Pump Market Size by Product (2019-2032)
- Market Overview
- Volumetric Infusion Pumps
- Insulin Infusion Pumps
- Syringe Infusion Pumps
- Enteral Infusion Pumps
- Patient-controlled Analgesia Pumps (PCA)
- Ambulatory Infusion Pumps
- Other Products
Global Intravenous Infusion Pump Market Size by Disease Indication (2019-2032)
- Market Overview
- Diabetes
- Chemotherapy
- Pediatrics/Neonatology
- Hematology
- Others
Global Intravenous Infusion Pump Market Size by Technology (2019-2032)
- Market Overview
- Smart Infusion Pumps
- Traditional Infusion Pumps
Global Intravenous Infusion Pump Market Size by Price Range (2019-2032)
- Market Overview
- Economical
- Mid-Range
- Premium
Global Intravenous Infusion Pump Market Size by End Use (2019-2032)
- Market Overview
- Hospitals & Clinics
- Home Care
- Ambulatory Surgical Centers (ASCs)
- Others
Global Intravenous Infusion Pump Market Size (2019-2032)
- North America (By Product, By Disease Indication, By Technology, By Price Range, & By End Use)
- US
- Canada
- Europe (By Product, By Disease Indication, By Technology, By Price Range, & By End Use)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
- Asia-Pacific (By Product, By Disease Indication, By Technology, By Price Range, & By End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America (By Product, By Disease Indication, By Technology, By Price Range, & By End Use)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Product, By Disease Indication, By Technology, By Price Range, & By End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Dashboard
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
Key Company Profiles
- Becton, Dickinson and Company (BD)
- Company Overview
- Product Portfolio Overview
- Financial Overview
- Key Developments
- The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
- Baxter International Inc.
- B. Braun SE
- ICU Medical, Inc.
- Fresenius Kabi
- Terumo Corporation
- Vygon SA
- Medtronic plc
- Mindray
- Nipro Corporation
- Trivitron Healthcare
- Moog, Inc.
- Iradimed
- Arcomed AG
- Micrel Medical Devices
- Woo Young Medical
- InfuSystem Holdings, Inc.
- JMS Co., Ltd.
- Eitan Medical
- Plenum Tech Pvt. Ltd.
